Could 2 Prostate Cancer Drugs, Apalutamide (Erleada) and Enzalutamide (Xtandi), Fight Disease in Earlier Stages?

SUNDAY, June 2, 2019 — Cutting-edge prostate cancer drugs that help extend life in the toughest cases might also be useful in fighting less aggressive tumors, two new clinical trials suggest.
Two drugs that interfere with cancer’s ability to use…
Source: Topamax